C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2002
10/10/2002	CA2440831A1 Combination therapy using cd40 and cd20 ligands
10/10/2002	CA2429108A1 .psi..epsilon.rack peptide composition and method for protection against tissue damage due to ischemia
10/09/2002	EP1247865A2 Antibody for use in therapy
10/09/2002	EP1246933A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
10/09/2002	EP1246923A2 Dna modification proteins
10/09/2002	EP1246918A2 Secreted proteins
10/09/2002	EP1246917A2 Human stra6 polypeptides
10/09/2002	EP1246915A2 Improved lysosomal enzymes and lysosomal enzyme activators
10/09/2002	EP1246905A2 Histone deacetylase-8 proteins, nucleic acids, and methods of use
10/09/2002	EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002	EP1246845A1 Method for making insulin precursors and insulin precursor analogs
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246843A1 Novel fgf homolog zfgf12
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002	EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40
10/09/2002	EP1246631A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
10/09/2002	EP1200475A4 Diagnostic method using expression of mn/ca9 protein in ascus pap smears
10/09/2002	EP1194445A4 Methods for protein purification using aqueous two-phase extraction
10/09/2002	EP0960336B1 Peptide reagent for the detection of human cytomegalovirus (cmv)
10/09/2002	EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002	EP0804562B1 Connective tissue growth factor-2
10/09/2002	EP0769025B1 Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown
10/09/2002	EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder
10/09/2002	EP0651761B1 Method for modification of recombinant polypeptides
10/09/2002	EP0640098B1 Canine coronavirus s gene and uses therefor
10/09/2002	CN1373799A Method for producing heterologous secreted protein from Chinese hamster ovary cells grown on microcarriers
10/09/2002	CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002	CN1373668A Hybrid peptide modulate immune response
10/09/2002	CN1373209A High-yield bacterial strain C-1027-20 for preparing Lidamycin as antineoplastic antibiotic
10/09/2002	CN1373141A Gene recombinant fibroblast growth factor-8a polypeptide and method for preparing same
10/08/2002	US6462256 Nucleic acid molecules from wheat, transgenic plant cells and plants and the thereof for the production of modified starch
10/08/2002	US6462255 Viral amplification of recombinant messenger RNA in transgenic plants
10/08/2002	US6462254 Detecting gene expression of fusion proteins
10/08/2002	US6462177 Mammalian blood loss-induced gene, kd312
10/08/2002	US6461867 Synthetic antigen presenting matrix
10/08/2002	US6461857 Observing absorbance as measurement of injury; applying as topical cosmetic with oxidation and ultraviolet radiation resistance
10/08/2002	US6461837 Methods for producing a polypeptide using a consensus translational initiator sequence
10/08/2002	US6461834 Clostripain catalyzed amidation of peptides
10/08/2002	US6461824 Production of chimeric antibodies with specificity to human tumor antigens
10/08/2002	US6461823 Death domain containing receptor-4 antibodies
10/08/2002	US6461821 Smooth muscle growth inhibitory composition, diagnostic method for arteriosclerosis, and kit therefor
10/08/2002	US6461811 Gamma-herpes virus DNA and methods of use
10/08/2002	US6461617 Recombinant toxin fragments
10/08/2002	US6461612 Genetic engineering
10/08/2002	CA2231046C Human protein kinases hyak3
10/08/2002	CA2108533C Monoclonal antibodies directed against ndp-kinase
10/08/2002	CA2047119C Vitro processing of fusion proteins
10/03/2002	WO2004031223A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof
10/03/2002	WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same
10/03/2002	WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002	WO2002077261A2 Human potassium channel
10/03/2002	WO2002077237A2 Transporters and ion channels
10/03/2002	WO2002077232A2 Compositions and methods relating to breast specific genes and proteins
10/03/2002	WO2002077221A1 Packaging cell lines for the continuous production of alphavirus vectors
10/03/2002	WO2002077218A1 Coagulation factor vii derivatives
10/03/2002	WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002	WO2002077211A2 A virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002	WO2002077195A2 Plasmodium falciparum ama-1 protein and uses thereof
10/03/2002	WO2002077179A2 Leinamycin biosynthesis gene cluster and its components and their uses
10/03/2002	WO2002077174A2 Human cytokine receptor
10/03/2002	WO2002077034A2 Modified granulocyte colony stimulating factor (g-csf) with reduced immunogenicity
10/03/2002	WO2002077033A1 Antibodies against cancer
10/03/2002	WO2002077028A1 Polypeptides and nucleic acids for bolekine
10/03/2002	WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002	WO2002077024A1 Shellfish protein
10/03/2002	WO2002077023A2 A new essential downstream component of the wingless signalling pathway
10/03/2002	WO2002077022A1 Immunogenic cell surface proteins of helicobacter pylori
10/03/2002	WO2002077016A2 Methods and apparatus for gel-free qualitative and quantitative proteome analysis, and uses therefore
10/03/2002	WO2002076578A1 Control of glycoforms in igg
10/03/2002	WO2002076503A1 Treatment of central nervous system diseases by antibodies against glatiramer acetate
10/03/2002	WO2002076502A1 Human medical treatment by application of immunoglobulin a
10/03/2002	WO2002076406A2 Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
10/03/2002	WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002	WO2002076389A2 Compositions and methods to prevent metastasis from primary malignancies
10/03/2002	WO2002076380A2 Cytotoxic factors for modulating cell death
10/03/2002	WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002	WO2002076196A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002	WO2002059153A3 Anticoagulants and their uses
10/03/2002	WO2002046226A3 Trefoil factor 2 (tff2) peptides with moiety attached to asn15
10/03/2002	WO2002034933A3 Methods and compositions for modifying biologically active target molecules
10/03/2002	WO2002026193A3 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
10/03/2002	WO2002024907A3 G-protein coupled receptor hfrbn63
10/03/2002	WO2002002751A3 Alteration of cell membrane
10/03/2002	WO2001098515A3 Gene-regulating conjugates
10/03/2002	WO2001079465A3 Nucleic acids encoding polypeptides having haloperoxidase activity
10/03/2002	WO2001071004A3 Proteases
10/03/2002	WO2001021812A9 Phosphatases which activate map kinase pathways
10/03/2002	WO2001019846A9 Transgenically produced fusion proteins
10/03/2002	WO1999047923A3 Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof
10/03/2002	US20020144310 Isolated polynucleotides and polypeptides relating to loci underlying resistance to soybean cyst nematode and soybean sudden death syndrome and methods employing same
10/03/2002	US20020144308 Viral amplification of recombinant messenger RNA in transgenic plants
10/03/2002	US20020144302 Expression vector coding protein for use in the treatment of liver disorders
10/03/2002	US20020143161 Members of the d52 gene family
10/03/2002	US20020143159 Bone morphogenetic protein (bmp)-17 and bmp-18 compositions
10/03/2002	US20020143155 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory defects
10/03/2002	US20020143150 Monoclonal antibody to the clonotypic structure of a T-cell receptor, a pharmaceutical composition and a diagnostic reagent comprising the same
10/03/2002	US20020142988 G-coupled receptor showing selective affinity for ATP
10/03/2002	US20020142986 Used in the diagnosis or prognosis of liver associated disorders

1 ... 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 ... 1125